News
-
White Paper Explores Healthcare-Specific Considerations for Artificial Intelligence
The International Organization for Standardization (ISO) has published a new white paper examining how the specific characteristics of healthcare influence the development, evaluation and implementation of artificial intelligence (AI). The report provides valuable insights for researchers and innovators working on AI-driven solutions in personalised medicine.
-
New Horizon Europe Call: Personalised Approaches to Reduce Adverse Drug Reactions
A new Horizon Europe call provides €38 million to support research into personalised approaches to improve medication safety and reduce adverse drug reactions in patients taking multiple medications. The call focuses on pharmacogenomics, biomarkers and digital technologies to enable safer, more effective and personalised treatment strategies.
-
IHI Publishes Draft Topics for Calls 14 and 15, with New Opportunities for Personalised Medicine
The Innovative Health Initiative (IHI) has published six draft topics for its upcoming Calls 14 and 15, expected to launch in early 2027. Several topics are particularly relevant to personalised medicine, addressing predictive health technologies, patient-centred care, advanced therapies and clinical evidence generation.
-
Announcement of Results – EP PerMed Twinning Call 2026
Six high-quality projects have been selected for funding under the EP PerMed Twinning Call 2026, an initiative designed to accelerate the implementation of personalised medicine approaches across Europe through the transfer of knowledge, expertise, and proven practices between healthcare organisations.
EP PerMed JTC2027
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
The EP PerMed Joint Transnational Call 2027 ‘Cell and Gene Therapy for Personalised Medicine’ (CGT4PM2027) aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine.
EP PerMed Stakeholder Forum
Join to move personalised medicine forward!
The EP PerMed Stakeholder Forum brings together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine (PM) on a single platform to accelerate the translation of research findings into clinical practice and marketable applications.
Showcase your own expertise and interests in personalised medicine, either scientifically or along the value chain for implementation. Find others with exactly the knowledge you need for your next steps or be found by others, who specifically need your advice. You can reach out to potentially interesting partners directly within the platform to initiate a first contact.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.